Ramy Farid
Chief Executive Officer bij SCHRÖDINGER, INC.
Vermogen: 63 M $ op 31-03-2024
Profiel
Ramy Farid bekleedt de functie van President, Chief Executive Officer & Director bij Schrdinger, Inc. Hij is tevens lid van de raad van bestuur van Nimbus Therapeutics LLC, Morphic Therapeutic, Inc., Nimbus Apollo, Inc. en Ajax Therapeutics, Inc. Voorheen bekleedde hij de functie van assistent-professor aan de Rutgers State University of New Jersey. Hij behaalde een doctoraat aan de Universiteit van Pennsylvania en een doctoraat aan het California Institute of Technology.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 15-03-2023 | 4 085 495 ( 2.92% ) | 58 M $ | 31-03-2024 | |
SCHRODINGER, INC.
0.29% | 04-03-2024 | 184 432 ( 0.29% ) | 5 M $ | 31-03-2024 |
Actieve functies van Ramy Farid
| Bedrijven | Functie | Begin |
|---|---|---|
| SCHRÖDINGER, INC. | Chief Executive Officer | 01-01-2017 |
| STRUCTURE THERAPEUTICS INC. | Director/Board Member | 01-04-2019 |
Nimbus Apollo, Inc.
 Nimbus Apollo, Inc. Pharmaceuticals: MajorHealth Technology Nimbus Apollo, Inc. provides drug discovery research services. The company is headquartered in Cambridge, MA. | Director/Board Member | - |
Ajax Therapeutics, Inc.
 Ajax Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ajax Therapeutics, Inc. operates as a biomedical company. The company is headquartered in New York, NY. | Director/Board Member | - |
Schrodinger, Inc. (Oregon)
 Schrodinger, Inc. (Oregon) Packaged SoftwareTechnology Services Schrodinger, Inc. is a private company based in Portland, OR. The company develops a drug discovery platform. | President | - |
Oak Hill Bio Corp.
 Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | Director/Board Member | 12-04-2022 |
Shanghai ShouTi Biotechnology Co., Ltd.
 Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Part of Structure Therapeutics, Inc., Shanghai ShouTi Biotechnology Co., Ltd. develops biotechnologies. The private company is based in Shanghai, China. The CEO of the Chinese company is Xi Chen Lin. | Director/Board Member | - |
Eerdere bekende functies van Ramy Farid
| Bedrijven | Functie | Einde |
|---|---|---|
| MORPHIC HOLDING, INC. | Director/Board Member | 01-06-2019 |
Morphic Therapeutic, Inc.
 Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Director/Board Member | - |
| ░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░ ░░░░░ ░░░░░░░░░░ ░░ ░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Opleiding van Ramy Farid
| Rochester Christian University | Undergraduate Degree |
| University of Pennsylvania | Doctorate Degree |
| California Institute of Technology | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| SCHRÖDINGER, INC. | Technology Services |
| MORPHIC HOLDING, INC. | Health Technology |
| STRUCTURE THERAPEUTICS INC. | Commercial Services |
| Bedrijven in privébezit | 7 |
|---|---|
Nimbus Therapeutics LLC
 Nimbus Therapeutics LLC BiotechnologyHealth Technology Nimbus Therapeutics LLC provides drug discovery research services. It is a computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. The company was founded by Bruce Lee Booth in 2009 and is headquartered in Cambridge, MA. | Health Technology |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Health Technology |
Nimbus Apollo, Inc.
Nimbus Apollo, Inc. Pharmaceuticals: MajorHealth Technology Nimbus Apollo, Inc. provides drug discovery research services. The company is headquartered in Cambridge, MA. | Health Technology |
Ajax Therapeutics, Inc.
Ajax Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ajax Therapeutics, Inc. operates as a biomedical company. The company is headquartered in New York, NY. | Health Technology |
Schrodinger, Inc. (Oregon)
Schrodinger, Inc. (Oregon) Packaged SoftwareTechnology Services Schrodinger, Inc. is a private company based in Portland, OR. The company develops a drug discovery platform. | Technology Services |
Shanghai ShouTi Biotechnology Co., Ltd.
Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Part of Structure Therapeutics, Inc., Shanghai ShouTi Biotechnology Co., Ltd. develops biotechnologies. The private company is based in Shanghai, China. The CEO of the Chinese company is Xi Chen Lin. | Health Technology |
Oak Hill Bio Corp.
Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | Commercial Services |
